Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
There are probably 70,000 more diabetic patients in this country using insulin today than there were a year ago, and I attribute this increase chiefly to the discovery of protamine insulin by Dr. Hagedorn of Copenhagen. His discovery stimulated the use of insulin and insulin it is which has lessened coma and made it inexcusable, has raised the life expectancy of 10 year old diabetic children from two years to 31.7 years, and has trebled the duration of diabetes for all diabetic patients and even deferred premature arteriosclerosis by two years or more. The simplicity and convenience of administering insulin once a day have appealed to the diabetic public, and is it any wonder that they have turned to it or that I should feel still more strongly now than a year and a half ago that, in recognition of this extension of the use of insulin—an indirect benefit—and of
JAMA – American Medical Association
Published: Aug 14, 1937
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.